The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review.

Tissue biomarkers could pivotally improve clinical outcome prediction following prostate cancer therapy. Clinically, prostate cancer is managed by diverse treatment modalities whose individual influence on a biomarker's predictive ability is not well understood and poorly investigated in the literature.